INR matters: A case on managing argatroban for bridging oral anticoagulation in a patient with heparin induced thrombocytopenia type II after mechanical heart valve replacement

Thrombosis Research

Volumn 124, Issue 2, 2009, Pages 242-243

  Raaz, Uwe ^a   Maegdefessel, Lars ^a   Buerke, Michael ^a   Janusch, Matthias ^a   Werdan, Karl ^a   Schlitt, Axel ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ARGATROBAN; HEPARIN;

AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; CARDIAC PATIENT; CASE REPORT; DRUG EFFICACY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EMBOLISM PREVENTION; EYE SURGERY; FEMALE; HEART LEFT VENTRICLE FAILURE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INTERNATIONAL NORMALIZED RATIO; LACRIMAL GLAND DISEASE; LETTER; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; SINUS RHYTHM; THROMBOEMBOLISM; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; AORTIC VALVE; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEPARIN; HUMANS; INTERNATIONAL NORMALIZED RATIO; PIPECOLIC ACIDS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 67249138585     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.08.023     Document Type: Letter

References (4)

1. Vahanian A., Baumgartner H., Bax J., Butchart E., Dion R., Filippatos G., et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 28 (2007) 230-268
2. Bartholomew J.R., and Hursting M.J. Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR). J Thromb Thrombolysis 19 (2005) 183-188
3. Hursting M.J., Lewis B.E., and Macfarlane D.E. Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia. Clin Appl Thromb Hemost 11 (2005) 279-287
4. Arpino P.A., Demirjian Z., and Van Cott E.M. Use of the chromogenic factor X assay to predict the international normalized ratio in patients transitioning from argatroban to warfarin. Pharmacotherapy 25 (2005) 157-164